MARKET

VCEL

VCEL

Vericel
NASDAQ

Real-time Quotes | Nasdaq Last Sale

15.71
-0.40
-2.48%
Closed 16:00 08/12 EDT
OPEN
16.25
PREV CLOSE
16.11
HIGH
16.40
LOW
15.59
VOLUME
541.22K
TURNOVER
--
52 WEEK HIGH
19.57
52 WEEK LOW
6.78
MARKET CAP
710.88M
P/E (TTM)
-11221.4286
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average VCEL stock price target is 23.40 with a high estimate of 32.00 and a low estimate of 20.00.

EPS

VCEL News

More
Vericel Q2 EPS $(0.18) Beats $(0.21) Estimate, Sales $20.01M Beat $18.87M Estimate
Vericel (NASDAQ:VCEL) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.21) by 14.29 percent. This is a 260 percent decrease over losses of $(0.05) per share from the same
Benzinga · 08/05 12:44
Vericel Q2 EPS $(0.18) Beats $(0.21) Estimate, Sales $20.00M Beat $18.87M Estimate
Vericel (NASDAQ:VCEL) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.21) by 14.29 percent. This is a 260 percent decrease over losses of $(0.05) per share from the same
Benzinga · 08/05 12:01
Vericel Q2 EPS $(0.18) Beats $(0.21) Estimate, Sales $20.00M Beat $18.87M Estimate
Vericel (NASDAQ:VCEL) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.21) by 14.29 percent. This is a 260 percent decrease over losses of $(0.05) per share from the same
Benzinga · 08/05 12:01
Vericel Reports Second Quarter 2020 Financial Results
Product Revenues of $20.0 Million Reported for the Second Quarter Conference Call Today at 8:30am Eastern TimeCAMBRIDGE, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and sev
GlobeNewswire · 08/05 12:00
Vericel Q2 2020 Earnings Preview
Vericel (NASDAQ:VCEL) is scheduled to announce Q2 earnings results on Wednesday, August 5th, before market open. The consensus EPS Estimate is -$0.20 and t
seekingalpha · 08/04 21:25
Vericel to Report Second-Quarter 2020 Financial Results on August 5, 2020
CAMBRIDGE, Mass., July 22, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the following webcast and conference call to discuss its second-quarter
GlobeNewswire · 07/22 12:30
Do Options Traders Know Something About Vericel (VCEL) Stock We Don't?
Investors need to pay close attention to Vericel (VCEL) stock based on the movements in the options market lately.
Zacks · 07/15 12:33
IPO Update: ACell Proposes $75 Million IPO Terms
Seeking Alpha - Article · 07/13 17:28

Industry

Pharmaceuticals
+2.16%
Pharmaceuticals & Medical Research
+1.79%

Hot Stocks

Symbol
Price
%Change

About VCEL

Vericel Corporation is an integrated, commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. The Company operates through the research, product development, manufacture and distribution of cellular therapies for use in the treatment of specific diseases.. Its autologous cell therapy products include Epicel (cultured epidermal autografts), which is a permanent skin replacement for the treatment of patients with deep-dermal or full-thickness burns. The Company is developing MACI, which is a third-generation autologous chondrocyte implant and ixmyelocel-T, which is a patient-specific multicellular therapy.
More

Webull offers kinds of Vericel Corp stock information, including NASDAQ:VCEL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VCEL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VCEL stock methods without spending real money on the virtual paper trading platform.